LIGANDROL LGD-4033 Ligandrol Sarms CAS NO.431579-34-9

product name: 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile(lgd-4033)

synonyms: 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile(lgd-4033);lgd-4033;4-[(2r)-2-[(1r)-2,2,2-trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile;4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile;ligandrol;4-[(2r)-2-[(1r)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile

cas: 1165910-22-4

mf: c14h12f6n2o

mw: 338.2482992

einecs:

product categories: sarms(selective androgen receptor modulator)

what is ligandrol(lgd-4033)

lgd-4033 is a selective androgen receptor modulator (sarms), and a novel non-steroidal oral sarm that binds to ar with high affinity (ki of ~1 nm) and selectivity. it’s in a class of androgen receptor (ar) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. lgd-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.

how it works

lgd-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. it demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. lgd-4033 has recently completed a phase i multiple ascending dose study in healthy volunteers.

dosages and suggestion

recommended maximum dose ligandrol the safety and tolerability up to doses of 22 mg -25mg . it has a half-life of 24 hours a day.